New cholesterol drug candidate tested in healthy volunteers
NCT ID NCT07655960
First seen Jun 26, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This early-stage trial tests a new drug called AJU-C716 against a reference drug (C716R) in 41 healthy adults aged 19 to 55. The goal is to see how safe the drug is and how the body processes it. This study does not test if the drug works for high cholesterol—it only looks at safety and drug levels in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AJU-C716 (test drug) and C716R (reference drug)
- What could go wrong
- This is a very early Phase 1 study in healthy volunteers, not patients. It only checks safety and drug levels, not whether the drug works for cholesterol. Many early-stage drugs fail to show benefit later.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H+ Yangji Hospital, Seoul, Republic of South Korea
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame high cholesterol?
- Ancient herbal mix put to the test against high cholesterol
- Cookies that could fight cholesterol: pumpkin seeds and walnuts put to the test
- Hormone therapy may shield menopausal hearts and brains — a trial puts it to the test
- Could vitamin d levels influence cholesterol in obese diabetes patients?
- Could a tropical oil and green exercise boost fat burning and calm your mind?